DPIs provide a major drug development opportunity for respiratory or systemic drug delivery and we have the technology platform to help.
Dry Powder Inhaler (DPI) Capsules
Our Dry Powder Inhaler capsules are custom engineered to allow more consistent bronchial delivery with their best-in-class attributes including:
- Inner surface properties that minimize powder adhesion to inside wall of the capsule for consistent dose delivery to patients
- Low moisture level shell with optimized puncture properties
- Strict microbial limits that comply with all global DPI regulatory guidelines
- Available in both DPI-specific gelatin or hypromellose capsules
Inhaler Technology Platform
Capsugel is at the forefront of the capsule-based dry powder inhaler (DPI) market sector – one of the fastest growing drug delivery categories worldwide.
Key drivers of our inhaler technology platform include:
- A range of ready-to-use capsule-based DPI solutions – HGCs, HPMC Capsules – designed to deliver any dose range for inhaled drugs
- Formulation and development possibilities for vaccines, gene therapy, hormone therapy, anti-infectives, analgesics, biologics and a continuously expanding range of therapies
- Comprehensive services, customized solutions and technical support to maximize stability, flexibility, yield, speed and efficiency
- Expertise and support in adherence to all global DPI capsule regulatory guidelines
- Xcelodose® high-precision filling machines offer fast, accurate filling directly into capsules at very low dose weights from 100 micrograms and help ensure powder is not compressed to facilitate evacuation on inhalation
- Technical training tailored to develop internal skills and knowledge, improve program performance and increase productivity
Related Links
Xcelodose® Precision Powder Filling Machine
Additional Resources
Hard Capsules for Dry Powder Inhalers: Performance on Puncturing